Table 3.
QT Cohort vs. CS Cohort | SW Cohort vs. CS Cohort | |||||||
---|---|---|---|---|---|---|---|---|
Estimate | SE | p-value | Estimate | SE | p-value | |||
Cohort (reference = CS) | 0.35 | 0.02 | < 0.001 | 0.32 | 0.10 | < 0.001 | ||
Time (reference = pre-index period) | -0.07 | 0.02 | < 0.001 | -0.07 | 0.02 | < 0.001 | ||
Cohort X Time | -0.10 | 0.03 | < 0.001 | -0.19 | 0.11 | 0.08 | ||
Deyo-Charlson Comorbidity Index | 0.24 | 0.003 | < 0.001 | 0.27 | 0.005 | < 0.001 | ||
COPD Exacerbation | 0.15 | 0.01 | < 0.001 | 0.16 | 0.01 | < 0.001 | ||
Cohort (reference = CS) | Estimated differences in changes of costs associated with changes in smoking behavior | |||||||
-$2,910 (-$4,485, $-1,335) |
804 | < 0.001 |
-$5,312 (-$11,067, $442) |
2,936 | 0.08 |